These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 17448396
61. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group. Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428 [Abstract] [Full Text] [Related]
62. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898 [Abstract] [Full Text] [Related]
63. Michigan Children's Immunization Registry: An important tool in reaching & maintaining 100% rates among two-year-olds. Haveman JK. Mich Med; 1996 Aug 20; 95(8):28. PubMed ID: 8840779 [Abstract] [Full Text] [Related]
64. Supplementary statement on conjugate meningococcal vaccines. National Advisory Committee on Immunization. Can Commun Dis Rep; 2003 Sep 01; 29():10-1. PubMed ID: 14526693 [No Abstract] [Full Text] [Related]
65. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Can Commun Dis Rep; 2007 Nov 01; 33(ACS-11):1-12. PubMed ID: 18064747 [No Abstract] [Full Text] [Related]
66. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM. Pediatrics; 2008 Mar 01; 121(3):562-9. PubMed ID: 18310206 [Abstract] [Full Text] [Related]
67. Assessing the ability of an immunization information system to prevent overimmunization of pediatric influenza vaccines. Carlton CA, Potter RC, Vranesich PA, Swanson RG. J Public Health Manag Pract; 2015 Mar 01; 21(3):282-7. PubMed ID: 25084536 [Abstract] [Full Text] [Related]
68. Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey. Smith PJ, Nuorti JP, Singleton JA, Zhao Z, Wolter KM. Pediatrics; 2007 Nov 01; 120(5):e1165-73. PubMed ID: 17974712 [Abstract] [Full Text] [Related]
69. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L. Pediatr Infect Dis J; 2009 Apr 01; 28(4 Suppl):S109-18. PubMed ID: 19325447 [Abstract] [Full Text] [Related]
70. Inadvertent misadministration of meningococcal conjugate vaccine--United States, June-August 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2006 Sep 22; 55(37):1016-7. PubMed ID: 16988640 [Abstract] [Full Text] [Related]
71. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007. Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep; 2008 Apr 18; 57(15):398-401. PubMed ID: 18418345 [Abstract] [Full Text] [Related]
72. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep; 2008 Apr 04; 57(13):343-4. PubMed ID: 18385642 [Abstract] [Full Text] [Related]
74. Vaccine co-administration in paediatric age: the experience of the Local Health Unit of Cuneo-1 (Ambito di Cuneo), Italy. Pellegrino A, Busellu G, Cucchi A, Cavallaro A, Gabutti G, Team of Territorial Paediatricians of LHU CN1 - (Ambito di Cuneo). Acta Biomed; 2010 Dec 04; 81(3):204-9. PubMed ID: 22530458 [Abstract] [Full Text] [Related]
75. Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003. McCauley MM, Stokley S, Stevenson J, Fishbein DB. J Adolesc Health; 2008 Dec 04; 43(6):540-7. PubMed ID: 19027641 [Abstract] [Full Text] [Related]
76. Meningococcal vaccines: a neglected topic in travel medicine? Wilder-Smith A. Expert Rev Vaccines; 2009 Oct 04; 8(10):1343-50. PubMed ID: 19803757 [Abstract] [Full Text] [Related]
77. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages. Fairbrother G, Broder K, Staat MA, Schwartz B, Heubi C, Hiratzka S, Walker FJ, Morrow AL. Pediatrics; 2007 Aug 04; 120(2):e401-9. PubMed ID: 17646354 [Abstract] [Full Text] [Related]
78. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Kafetzis DA, Stamboulidis KN, Tzanakaki G, Kourea Kremastinou J, Skevaki CL, Konstantopoulos A, Tsolia M. Clin Microbiol Infect; 2007 May 04; 13(5):550-2. PubMed ID: 17378929 [Abstract] [Full Text] [Related]
79. Increasing adolescent vaccination: barriers and strategies in the context of policy, legal, and financial issues. Ford CA, English A, Davenport AF, Stinnett AJ. J Adolesc Health; 2009 Jun 04; 44(6):568-74. PubMed ID: 19465321 [Abstract] [Full Text] [Related]
80. Meningococcal Vaccination Among Adolescents in the United States: A Tale of Two Age Platforms. Kurosky SK, Esterberg E, Irwin DE, Trantham L, Packnett E, Novy P, Whelan J, Hogea C. J Adolesc Health; 2019 Jul 04; 65(1):107-115. PubMed ID: 31103378 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]